Cargando…
Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir “S-217622”: A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species
[Image: see text] Lately, nitrogenous heterocyclic antivirals, such as nucleoside-like compounds, oxadiazoles, thiadiazoles, triazoles, quinolines, and isoquinolines, topped the therapeutic scene as promising agents of choice for the treatment of the severe acute respiratory syndrome coronavirus 2 (...
Autores principales: | Eltayb, Wafa A., Abdalla, Mohnad, Rabie, Amgad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897045/ https://www.ncbi.nlm.nih.gov/pubmed/36798145 http://dx.doi.org/10.1021/acsomega.2c03881 |
Ejemplares similares
-
Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2
por: Yang, Yujian, et al.
Publicado: (2023) -
Promising Experimental
Anti-SARS-CoV-2 Agent
“SLL-0197800”: The Prospective Universal Inhibitory
Properties against the Coming Versions of the Coronavirus
por: Rabie, Amgad M., et al.
Publicado: (2023) -
Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant
por: Abdalla, Mohnad, et al.
Publicado: (2023) -
Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study
por: Rabie, Amgad M., et al.
Publicado: (2023) -
Two-stage one-pot synthetic strategy for the key triazone-triazole intermediate of ensitrelvir (S-217622), an oral clinical candidate for treating COVID-19
por: Hu, Wei, et al.
Publicado: (2022)